Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Sights, sounds, and scents: a new way to soothe ICU patients?

NCT ID NCT06577870

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding calming visual, auditory, and olfactory elements to the hospital room can reduce discomfort for patients in intensive care or continuing care units. About 208 adults hospitalized for at least 48 hours will be offered this immersive sensory environment. Researchers will measure discomfort using a standard questionnaire to see if this approach helps patients feel better during their stay.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
immersive sensory environment (visual, auditory, olfactory projections)
What this could lead to
If effective, this approach could offer a drug-free way to ease discomfort for patients in intensive care, improving their hospital experience.
What could go wrong
This is a relatively small, early-stage study, and the benefits may not be large or apply to all patients. The sensory setup may also be distracting or overwhelming for some.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 208 people

The number the study aims to enrol. It can still change while the study runs.

Started

May 2025

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age ≥ 18 years ; * Patient hospitalized in intensive care or continuing care unit for an estimated minimum of 48 hours; * Patient hospitalized for a medical indication (including in the pre-surgical phase) or in the post-surgical phase; * Patient or support person who speaks and understands French, has understood the research procedures and is able to complete the questionnaires; * For women of childbearing age (non-menopausal), even for those on contraception: negative pregnancy test (urinary); If positive: completed by a biological test; * Patient or trusted support person having been informed and having signed an informed consent form to participate in the study. Exclusion Criteria: * Deaf or blind patient; * Asthmatic patient with background treatment; * Epileptic patient or known history of convulsion; * Known allergy or intolerance to essential oils or to a component of essential oils; * Patient transferred from another intensive care unit; * Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision); * Breast-feeding or pregnant women; * Patient or support person unable to understand information relating to the study (linguistic, psychological, cognitive, etc.); * Unconscious patient with no relative or support person present; * Homeless patient; * Patient with known severe psychiatric illness such as chronic hallucinatory psychosis or paranoid syndrome; * Patient participating in or being excluded from another clinical trial; * Patient not covered by a social security scheme.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hospitalism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Hôpital Privé Jacques Cartier

    RECRUITING

    Massy, 91300, France